- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02947204
Oxygen Saturation Monitoring in Bronchiolitis
Intermittent vs. Continuous Oxygen Saturation Monitoring in Infants Hospitalized for Bronchiolitis: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
BACKGROUND This research protocol focuses on bronchiolitis, a leading cause of infant hospitalization and cumulative expense for the health care system. Supportive management, such as oxygen supplementation and monitoring, is the major focus of care, as active medical treatment is not effective. Oxygen saturation monitoring may be performed on an intermittent (e.g. every 4-6hrs) or continuous basis for stable infants hospitalized with bronchiolitis. Observational studies find that the use of continuous monitoring is associated with overuse of supplemental oxygen and longer hospital stay. Based on this low quality evidence, practice guidelines state that clinicians may choose not to use continuous monitoring and practice variation exists due to a lack of RCTs.
SPECIFIC AIMS Primary: To determine if intermittent vs continuous oxygen saturation monitoring will reduce length of hospital stay in infants with bronchiolitis. Secondary: To determine differences in other outcomes - effectiveness, safety, acceptability, and cost.
METHODOLOGY Design: multi-centre, pragmatic, parallel group, 1:1, two arm superiority RCT. Population: Previously healthy infants (4 weeks-2 years) hospitalized with bronchiolitis who are clinically stable, will be recruited from children's and community hospitals in Ontario, Canada.
Interventions: Randomization to intermittent (every 4hrs) or continuous oxygen saturation monitoring. In keeping with local and national clinical practice guidelines, an acceptable oxygen saturation target of ≥ 90% will be used for both groups.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 2Z5
- McMaster Children's Hospital
-
Mississauga, Ontario, Canada, L5B 1B8
- Trillium Health Partners (Credit Valley Site)
-
Oshawa, Ontario, Canada, L1G 2B9
- Lakeridge Health Oshawa
-
Ottawa, Ontario, Canada, K1H 8L1
- Children's Hospital of Eastern Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- Hospital for Sick Children
-
Toronto, Ontario, Canada, M2K 1E1
- North York General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Children admitted to the general pediatric inpatient unit (GPIU) with bronchiolitis will be eligible if their clinical status is stable and not at high risk of deterioration
Inclusion Criteria:
- Clinical diagnosis of bronchiolitis as determined by the attending physician.
- First episode of acute bronchiolitis.
- Age: 4 weeks to 24 months.
- Clinical status stable for 6 hours
- Parent consent
Exclusion Criteria:
- Known risk factors for clinical deterioration including chronic medical condition; premature birth (<35weeks), history of apnea, weight < 4kg, receiving morphine
- Patient on heated high flow oxygen at enrolment
- ICU admission on current admission
- No telephone available
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Continuous oxygen monitoring
Oxygen saturation will be measured continuously through the child's hospital stay until discharge.
|
Oxygen saturation will be measured continuously through the child's hospital stay until discharge.
Vital signs will be completed every 4 hours.
Other Names:
|
Experimental: Intermittent oxygen monitoring
Oxygen saturation will be measured intermittently, every 4 hours, through the child's hospital stay until discharge.
|
Oxygen saturation and vital signs will be measured intermittently at a frequency of every 4 hours by the bedside nurse through the child's hospital stay until discharge.
Vital signs will be completed every 4 hours.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Length of hospital stay from randomization on the inpatient unit to discharge from hospital
Time Frame: 1 month
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of oxygen supplementation from randomization to discontinuation of supplementation
Time Frame: 1 month
|
1 month
|
|
Number of medical interventions performed from time of randomization to hospital discharge
Time Frame: 1 month
|
1 month
|
|
Time from randomization to meeting hospital discharge criteria
Time Frame: 1 month
|
1 month
|
|
Length of hospital stay from inpatient unit admission to hospital discharge
Time Frame: 1 month
|
1 month
|
|
Parent anxiety
Time Frame: 1 month
|
Parents will rate their level of anxiety at the current time (state anxiety) and generally (trait anxiety) from the adult State Trait Anxiety Inventory questionnaire during the hospital stay.
|
1 month
|
Number of parent work days missed from randomization to 15 days after discharge
Time Frame: 15 days after discharge
|
15 days after discharge
|
|
Nursing satisfaction
Time Frame: 1 month
|
The attending nurse will be asked to complete a 10 mm visual analogue scale (VAS) to measure their satisfaction with the quality of monitoring.
|
1 month
|
PICU admission after randomization
Time Frame: 1 month
|
1 month
|
|
PICU consultation after admission
Time Frame: 1 month
|
1 month
|
|
Unscheduled return to care within 15 days of discharge
Time Frame: 15 days after discharge
|
15 days after discharge
|
|
Mortality
Time Frame: 15 days after discharge.
|
15 days after discharge.
|
|
Cost-Effectiveness
Time Frame: 15 days after discharge.
|
Cost-effectiveness will be measured by the incremental cost-effectiveness ratio (ICER), a ratio defined by the incremental difference in costs between treatment arms and the incremental difference in length of stay.
|
15 days after discharge.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sanjay Mahant, The Hospital for Sick Children
Publications and helpful links
General Publications
- Mahant S, Wahi G, Bayliss A, Giglia L, Kanani R, Pound CM, Sakran M, Kozlowski N, Breen-Reid K, Arafeh D, Moretti ME, Agarwal A, Barrowman N, Willan AR, Schuh S, Parkin PC; Canadian Paediatric Inpatient Research Network (PIRN). Intermittent vs Continuous Pulse Oximetry in Hospitalized Infants With Stabilized Bronchiolitis: A Randomized Clinical Trial. JAMA Pediatr. 2021 May 1;175(5):466-474. doi: 10.1001/jamapediatrics.2020.6141.
- Mahant S, Wahi G, Giglia L, Pound C, Kanani R, Bayliss A, Roy M, Sakran M, Kozlowski N, Breen-Reid K, Lavigne M, Premji L, Moretti ME, Willan AR, Schuh S, Parkin PC. Intermittent versus continuous oxygen saturation monitoring for infants hospitalised with bronchiolitis: study protocol for a pragmatic randomised controlled trial. BMJ Open. 2018 Apr 20;8(4):e022707. doi: 10.1136/bmjopen-2018-022707.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1000054699
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchiolitis
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft vs Host Disease | Constrictive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Hillel Yaffe Medical CenterCompletedReflexology | Bronchiolitis; ChemicalIsrael
-
Guy's and St Thomas' NHS Foundation TrustCompletedAcute Viral BronchiolitisUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Viral BronchiolitisFrance
-
Ministry of Health, SpainCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedBronchiolitis Obliterans | Graft Versus Host Disease | Graft-Versus-Host Disease | Constructive Bronchiolitis | Bronchiolitis, Exudative | Bronchiolitis, ProliferativeUnited States
-
Hospices Civils de LyonRecruiting
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Viral BronchiolitisFrance
-
University Hospital, Basel, SwitzerlandRecruitingBronchiolitis Obliterans Syndrome (BOS) | Bronchiolitis Obliterans (BO)Switzerland, Saudi Arabia
-
Groupe Hospitalier du HavreCompletedAcute Viral BronchiolitisFrance
Clinical Trials on Continuous oxygen monitoring
-
The Hospital for Sick ChildrenCompleted
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedSeptic Shock | Severe SepsisBrazil
-
Association Nationale pour les Traitements A Domicile...RecruitingLUNG DISEASES, OBSTRUCTIVEFrance
-
Turtle Shell Technologies Pvt. Ltd.Eastside Research Associates; HealthMindsCompletedNo Specific Medical Conditions or Disease StatesUnited States
-
Charles University, Czech RepublicUnknown
-
Senseonics, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1United States
-
Kinderkrankenhaus auf der BultSenseonics, Inc.Completed
-
The Cleveland ClinicNot yet recruiting
-
Charles University, Czech RepublicUnknownDiabetes Mellitus, Type 1Czechia
-
Biobeat Technologies Ltd.CompletedHypotension of HemodialysisIsrael